Lessons from ambulatory electrocardiography.

The heart and tuberous sclerosis. An echocardiographic and electrocardiographic study.

Cross sectional echocardiography, 12 lead electrocardiography, and 24 hour ambulatory electrocardiography were performed in eleven patients with tuberous sclerosis. Echocardiography showed single or multiple intramyocardial masses, most commonly in the ventricular septum, suggestive of rhabdomyomata in seven of the eleven cases. One patient with a normal echocardiogram showed ventricular pre-ex...

Utility of Duranta, a wireless patch-type electrocardiographic monitoring system developed in Japan, in detecting covert atrial fibrillation in patients with cryptogenic stroke

RATIONALE Subcutaneous implantable electrocardiographs are highly effective in detecting covert atrial fibrillation (AF) in cryptogenic stroke. However, these invasive devices are not indicated for all cryptogenic stroke patients, and noninvasive improvements over conventional Holter-type ambulatory electrocardiography are needed. We evaluated the clinical application and effectiveness of Duran...

Using ambulatory electrocardiography during recovery from cardiac surgery.

diac monitoring may need to expand from the hospital to the home. We just completed a study in which we used intermittent loop recorders, a type of ambulatory electrocardiographic (ECG) device, to examine the incidence, timing, and symptoms of and risk factors for postoperative atrial fibrillation. In this article, we describe ambulatory ECG, discuss how we used this technique to monitor for at...

48-hour ambulatory electrocardiography in dynamite workers and controls.

Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.

The effect of Corwin, a new oral beta, partial agonist, on the ventricular response to atrial fibrillation was studied in digitalised patients during 24 hour ambulatory electrocardiography and during exercise on a treadmill in a double blind placebo controlled crossover trial. Corwin reduced the maximum heart rate during exercise from 162(16) beats/min to 120(9) beats/min and reduced the peak h...